FIELD: medicine.
SUBSTANCE: method involves determining chemoluminescence intensity and ceruloplasmin activity before beginning antitumor mammary carcinoma treatment in the cases of III-IV disease stage. Ratio coefficient of chemoluminescence intensity and ceruloplasmin activity being found 8-12 times as small when compared to healthy people, tumor development process generalization is considered to be the case. The value being found 2-3 times as low, no generalization is considered to be the case.
EFFECT: high accuracy and simplicity of the method.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING BRAIN METASTATIC INJURIES GENERALIZATION | 2005 |
|
RU2300104C2 |
PROGNOSIS OF TREATMENT EFFECTIVENESS FOR III-IV-STEP BREAST CANCER PATIENTS | 2003 |
|
RU2254576C2 |
METHOD FOR DETERMINATION OF MALIGNANT PROCESS ABUNDANCE | 2005 |
|
RU2289815C1 |
METHOD FOR TREATING OVARY CANCER | 1999 |
|
RU2163152C1 |
METHOD FOR PREDICTING GENERALIZATION OF MAMMARY CANCER | 2001 |
|
RU2204836C2 |
METHOD OF FORECASTING OF AUTOHEMOCHEMIOTHERAPY EFFICIENCY AT PATIENTS WITH RELAPSES AND METASTASISES OF UTERUS NECK CANCER | 2007 |
|
RU2352942C1 |
METHOD FOR PREDICTION OF RECURRENT VULVAR CANCER | 2013 |
|
RU2517541C1 |
METHOD FOR FORECASTING METASTASIS OF BREAST CANCER IN THE BONES | 2017 |
|
RU2663467C1 |
METHOD FOR TREATING MALIGNANT TUMORS | 2001 |
|
RU2210390C2 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
Authors
Dates
2004-12-10—Published
2002-06-04—Filed